SBIR/STTR Research Award
Universal Liquid Chromatography Detector Utilizing Reactive Flame Ionization Detection
Award amount
$78,518Program and phase
SBIR · Phase IAward year
2018Award details
- Awarding agency
- Department of Health and Human Services
- Branch
- National Institutes of Health
- Recipient company
- Activated Research Company, LLC
- Proposal award date
- 2018-02-01
- Contract end date
- 2019-07-31
- UEI
- M5UDDCBTBD97
- Solicitation number
- PA16-302
- Topic code
- 400
Research abstract
Abstract
The analysis of moleculesanalytesby liquid chromatographyLCis performed in all areas of healthcare from
drug discovery and development to disease diagnosisHerewe propose a near universal LC detector utilizing
a flame ionization detectorFIDthat responds with high sensitivity to all organic compoundsThis technology
has the potential to speed up pharmaceutical development and allow for more accurate quantification of the
components in pharmaceuticalsUltimatelythis will improve all aspects of healthcare that rely on LCThis
research and potential commercialization is supported by our concurrent development and product launch
success with corporate partners in the gas chromatographyGCmarketThe purpose of LC is to determine how
much of each molecule is in a sampleBecause of the complexity associated with the number of molecules that
exist in a sampleLC can be the most time consuming analytical technique in pharmaceutical developmentNeverthelessit is still the best technique for molecular quantification of pharmaceuticalsLC relies on two
equally important primary stepsseparation followed by detectionSeparation technologies have evolved over
recent years to increase chromatographic resolution and speed up analysisSimilarlydetectors such as mass
spectrometersMShave become more sensitive and selectiveallowing users to quickly identify components
in a complex matrixThe UV detector is used by andgtof LC users for quantification because it is low cost and
reliableHowevereven with modern improvementsthe UV detector cannot overcome its fundamental limitationwhich is its non uniform response to organic moleculesresulting in missed detection and sometimes poor
quantificationOur proposed product is a higher performingyet low costalternative to the UV detectorThe
specific aims of this proposal include the proof of concept testing necessary for utilization of an FID with an LCWith overyears of practice in GCthe FID has proven to be a sensitive and reliable detector with a linear
range over seven orders of magnitudeImplementation of the FID in LChoweverrequires the removal of the
mobile phasewhich would otherwise drown out the signal of analytesPrevious attempts of solvent removal
have been unsuccessful due to the challenges of continuous solvent removal and the requisite transfer of
nonvolatile analytes to the detectorAdvances in catalytic microreactor technologypioneered by Activated
Research Companynow provide the technology necessary for the implementation of FID in LCSuccessful
completion of the Phase I aims will lead to a Phase II commercialization strategy to bring this product to
healthcare marketsThis proposal has obtained the enthusiastic support of leading LC and pharmaceutical
companies offering a high probability of commercialization after meeting the project milestones Project Narrative
The development of a universal detector for liquid chromatography will lead to fastermore efficientdevelopment of pharmaceuticals and could result in enhanced healthless illnessesand longer lives
Technology keywords
Not reported
Other awards by this recipient
Verified by the same UEI. These are other public SBIR/STTR award pages, not a merged company record.
- SBIR Phase II: A carbon selective detector for liquid phase chemical detection of organic molecules
- SBIR Phase I: A universal carbon detector for liquid phase chemical detection of organic molecules